Prostate Specific Antigen - Quest Diagnostics
Prostate Specific Antigen PSA Coverage Indications, Limitations, and/or Medical Necessity Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer. Three to 6 months after radical prostatectomy, PSA is reported to provide a sensitive indicator ...
Download Prostate Specific Antigen - Quest Diagnostics
Information
Domain:
Source:
Link to this page:
Documents from same domain
Priority Value Tables - Quest Diagnostics
www.questdiagnostics.comPriority Value Tables by Testing Department For Use by Quest Diagnostics Clients and Employees Effective May 2017 Page 1 of 8 (replaces all previous versions)
Toxicology CPT Code Changes for 2017 - Quest …
www.questdiagnostics.comToxicology CPT Code Changes for 2017 Beginning January 1, 2017, there are new presumptive (screen) toxicology CPT codes that will replace the existing
Toxicology CPT Code Changes for 2017
www.questdiagnostics.comToxicology CPT Code Changes for 2017 Beginning January 1, 2017, there are new presumptive (screen) toxicology CPT codes that will replace the existing
Patient Request to Access or to ... - Quest …
www.questdiagnostics.comPatient Request to Access or to Disclose Protected Health Information (PHI) In order for us to identify the requested patient PHI, please complete all required information.Using the information provided, we will attempt to identify the
MI - Quest Diagnostics
www.questdiagnostics.comLast Updated: QuestDiagnostics.com Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics.
Glycated Hemoglobin/Glycated Protein
www.questdiagnostics.comCPT: Code Description Medicare National Coverage Determination Policy The ICD10 codes listed below are the top diagnosis codes currently utilized by ordering physicians
Helping insured patients get quality testing at …
www.questdiagnostics.comHelping insured patients get quality testing at lower costs UnitedHealthcare members are getting a stronger network. Beginning January 1, 2019, Quest Diagnostics will be innetwork with UnitedHealthcare (UHC) acro- ss all geographies, in
Medicare National Coverage Determinations (NCD) …
www.questdiagnostics.com*April 2018 Changes ICD-10-CM Version – Red Fu Associates, Ltd. April 2018 1 Medicare National Coverage Determinations (NCD) Coding Policy …
Individual with Documented Thrombotic Episode …
www.questdiagnostics.comIndividual with Documented Thrombotic Episode or at High Risk First Line Testing Second Line Testing . Rule Out. Test Plasma . Interpretation. Prothrombin
Medicare National and Local Coverage ... - Quest …
www.questdiagnostics.comThis list was compiled from Medicare’s Limited Coverage Policies for informational and reference purposes only. For the most current information please reference www.cms.gov.
Related documents
Coding Urology (Male) Procedures - AHIMA
campus.ahima.orgReference: CPT Assistant, May 2001, Page: 5 Hospital vs. ASC centers • Unit “1” vs. “2” 15 General Use of Modifiers CPT/ HCPCS SI Description 2007 final rule Device A Device A Description Modifier FB or FC in 2008 50387 T Ureteral stent exchange/remove 0122 C1875 Stent, coated/cov w/o del sy
PYLARIFY® (PIFLUFOLASTAT F 18) INJECTION FOR PET/CT …
www.pylarify.comprostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: • with suspected metastasis who are candidates for initial definitive therapy. • with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. Important Safety Information Contraindications None. Warnings and Precautions